Comments on FDA workshop draft agenda (harmful lifestyle/symptom drugs instead of critically needed fundamental pathophysiology drugs)

This is not my written testimony. That is here.

This post contains my predictions, which I posted elsewhere before the meeting, based on their misplaced focus on symptoms.

UPDATE: the FDA's "Meeting Summary", April 26, 2014, makes it clear that all of the concerns in this post have been borne out. The FDA is not serious.